Skip to main content
Glama

Google_ads

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/idempotent annotations, the description discloses real behavior: internal cascading through multiple lookup endpoints, graceful degradation when GLEIF/OpenFIGI fail, explicit `unresolved` fields instead of silent omission, and source-labelled identifiers. No statement contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a long, densely parenthetical wall of text that front-loads purpose but buries details inside run-on sentences. Most content is valuable, but repeated query examples and heavy nesting make it harder to parse than a bulleted or shorter version.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of return semantics and largely meets it: it names the outputs (CIK, ticker, company_name, LEI, FIGI, RxCUI, ingredient, brand), explains ownership resolution, and specifies failure/ambiguity behavior (`unresolved`, `figi_candidates`). It is complete enough for an agent to know what it will receive.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even with 100% schema coverage, the description expands parameter meaning: company values may be ticker, CIK, ISIN, or name; non-ticker instruments like bonds still resolve; ambiguous names return candidates; and the drug path yields RxCUI + ingredient + brand. It also reinforces the critical 'ENTITY NAME ONLY' constraint from the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific action—resolving a user-spoken name to canonical/official identifiers—and backs it with concrete query examples for ticker/CIK/LEI/RxCUI. It distinguishes itself from related tools like entity_profile and compare_entities by framing the output as the IDs that other tools require as input, and enumerates supported types ('company', 'drug').

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit trigger guidance: 'Use FIRST whenever you have a name but need an ID,' plus example questions that should route here. It does not name alternative sibling tools or give a clear when-not-to-use condition, though the ambiguity rule (return figi_candidates rather than asserting) is a useful guardrail.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Google_ads toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

The five gads_* tools are distinct, but the majority of the surface is a sprawling research/meta toolkit with many overlapping retrieval entry points: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, discover_tools, suggest_questions, validate_claim, entity_profile, compare_entities, recent_changes, and search_within all cover overlapping information-query territory. An agent could easily misroute a question among the ask_pipeworx variants or between the general-query and company-profile tools.

Naming Consistency3/5

Domain prefixes like gads_, polymarket_, and ask_pipeworx_ provide some structure, but naming conventions are mixed: gads_list_campaigns and list_subscriptions follow verb_noun, while entity_profile, ai_visibility_check, remember, and generate_llms_txt do not. The names are readable and grouped by prefix, but they do not form one consistent pattern.

Tool Count2/5

At 36 tools this is a large surface, and the count becomes even more problematic because the server is named Google_ads while only 5 of the 36 tools relate to Google Ads. The other 31 tools are a broad Pipeworx data-research, prediction-market, memory, and subscription utility set, which makes the server feel bloated and mis-scoped for its advertised purpose.

Completeness2/5

As a Google Ads server, the surface is read-only and incomplete: it can list campaigns and ad groups, get campaign details, pull metrics, and run GAQL, but it cannot create, update, or delete campaigns, manage budgets and bids, or handle keywords, audiences, or ad creatives. The many unrelated data-research tools do not address these core Google Ads management gaps.

Resources